CELLTHEON: YOUR PARTNER FROM cDNA THROUGH MANUFACTURING
Located in the San Francisco Bay Area – a center of excellence in Biotechnology, Celltheon is a leader in mammalian expression technologies. Celltheon's mammalian expression platform addresses the industry's key pain points:
- Low Expression and Difficult to Express Proteins (DEPs)
- Sub-optimal Product Quality
- Cell Line Instability
- Difficulty with process transferability & scalability
Using our industry leading CELLTHEON SMART™ Platform and our deep know-how, we provide Cell Line and Process Development services to make your bio-therapeutics commercially viable:
- Antibody fragments
- Difficult to express proteins
- Fc-fusion proteins
- mAbs
Celltheon has worked on >60 client projects ranging from preclinical to clinical stage therapeutics for indications such as oncology, inflammation, neuro-degeneration, obesity, and various lysosomal storage disorders. Two molecules have advanced to BLA and are awaiting commercial approval. Celltheon has granted 11 commercial licenses to date in addition to several R&D licenses.
The CELLTHEON SMART™ Technology Platform and services significantly reduce timelines, lower costs, increase efficiencies, ensure consistent product quality and accelerate decision making associated with development of biotherapeutics. As an innovative technology development company, Celltheon continues to develop cutting-edge technologies that improve the manufacturability and efficacy of biologics. Celltheon has several patents pending and has received broad, granted patents that encompass many applications of its platform technologies.
Whether you have a single molecule, or a development pipeline to take from cDNA to Manufacturing, contact us to leverage our robust technology platform, our know-how, our track record of success and our manufacturing partners.
